Keyphrases
Non-associated
100%
Stereotactic Body Radiation Therapy
100%
Local Control
100%
Clinical Stage I
100%
Stage I Lung Cancer
100%
Treatment Schedule
100%
Confidence Interval
75%
Local Failure
75%
Lung Stereotactic Body Radiation Therapy
75%
Odds Ratio
50%
Overall Survival
50%
Multivariable Logistic Regression
50%
Increased Mortality
50%
Propensity-matched Analysis
50%
Hazard Ratio
25%
Failure Rate
25%
Median Overall Survival
25%
Clinical Concerns
25%
Patient Characteristics
25%
Radiation Therapy
25%
Difference in Medians
25%
Treatment Outcome
25%
Kaplan-Meier Analysis
25%
Multi-institutional
25%
Local Recurrence
25%
Treatment Failure
25%
Non-small Cell Lung Cancer Patients
25%
Mortality Hazard
25%
Early-stage Lung Cancer
25%
Cox Proportional Hazards Modeling
25%
Central Tumor
25%
Patient Scheduling
25%
Scheduling Control
25%
Medicine and Dentistry
Clinical Stage
100%
Non Small Cell Lung Cancer
100%
Stereotactic Body Radiation Therapy
100%
Overall Survival
42%
Lung
42%
Logistic Regression Analysis
28%
Odds Ratio
28%
Neoplasm
14%
Hazard Ratio
14%
Kaplan Meier Method
14%
Recurrent Disease
14%
Patient Characteristics
14%
Mathematics
Confidence Interval
100%
Treatment Schedule
100%
Logistic Regression
66%
Odds Ratio
66%
Hazard Ratio
33%
Cancer Patient
33%
Kaplan-Meier
33%
Failure Rate
33%
Proportional Hazard
33%
Nursing and Health Professions
Non Small Cell Lung Cancer
100%
Stereotactic Body Radiation Therapy
100%
Confidence Interval
42%
Overall Survival
42%
Odds Ratio
28%
Logistic Regression Analysis
28%
Neoplasm
14%
Hazard Ratio
14%
Recurrent Disease
14%
Kaplan Meier Method
14%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Overall Survival
60%
Neoplasm
20%
Recurrent Disease
20%